From Insight to Modulation of CXCR4 and ACKR3 (CXCR7) Function

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Chemokine receptors CXCR4 and atypical chemokine receptor 3 (ACKR3/CXCR7) are highly expressed in a range of tumors. Yet, their role in cancer progression is not well understood. This minireview series encompasses seven comprehensive reviews focusing on modulators (small molecules, pepducins, antibodies), structural aspects, spatio-temporal signaling properties, and phosphorylation/interactome of CXCR4 and ACKR3. Moreover, different (patho)physiologic aspects and roles of these receptors in immunologic and oncogenic processes are discussed. SIGNIFICANCE STATEMENT: CXCR4 and atypical chemokine receptor 3 are two oncogenic G protein-coupled receptors that are highly upregulated in various tumors. Insight into the signalling properties of these receptors and the availability of modulators targeting these receptors are essential to assess their role in cancer.

Original languageEnglish
Pages (from-to)735-736
Number of pages2
JournalMolecular pharmacology
Volume96
Issue number6
DOIs
Publication statusPublished - 1 Dec 2019

Fingerprint

Chemokine Receptors
Immunologic Receptors
Neoplasms
G-Protein-Coupled Receptors
Phosphorylation
Antibodies

Cite this

@article{d6c64ef3c0c54c8a9cfaf13c7947e952,
title = "From Insight to Modulation of CXCR4 and ACKR3 (CXCR7) Function",
abstract = "Chemokine receptors CXCR4 and atypical chemokine receptor 3 (ACKR3/CXCR7) are highly expressed in a range of tumors. Yet, their role in cancer progression is not well understood. This minireview series encompasses seven comprehensive reviews focusing on modulators (small molecules, pepducins, antibodies), structural aspects, spatio-temporal signaling properties, and phosphorylation/interactome of CXCR4 and ACKR3. Moreover, different (patho)physiologic aspects and roles of these receptors in immunologic and oncogenic processes are discussed. SIGNIFICANCE STATEMENT: CXCR4 and atypical chemokine receptor 3 are two oncogenic G protein-coupled receptors that are highly upregulated in various tumors. Insight into the signalling properties of these receptors and the availability of modulators targeting these receptors are essential to assess their role in cancer.",
author = "Smit, {Martine J.} and {van Muijlwijk-Koezen}, {Jacqueline E.}",
year = "2019",
month = "12",
day = "1",
doi = "10.1124/mol.119.118364",
language = "English",
volume = "96",
pages = "735--736",
journal = "Molecular pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "6",

}

From Insight to Modulation of CXCR4 and ACKR3 (CXCR7) Function. / Smit, Martine J.; van Muijlwijk-Koezen, Jacqueline E.

In: Molecular pharmacology, Vol. 96, No. 6, 01.12.2019, p. 735-736.

Research output: Contribution to JournalArticleAcademicpeer-review

TY - JOUR

T1 - From Insight to Modulation of CXCR4 and ACKR3 (CXCR7) Function

AU - Smit, Martine J.

AU - van Muijlwijk-Koezen, Jacqueline E.

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Chemokine receptors CXCR4 and atypical chemokine receptor 3 (ACKR3/CXCR7) are highly expressed in a range of tumors. Yet, their role in cancer progression is not well understood. This minireview series encompasses seven comprehensive reviews focusing on modulators (small molecules, pepducins, antibodies), structural aspects, spatio-temporal signaling properties, and phosphorylation/interactome of CXCR4 and ACKR3. Moreover, different (patho)physiologic aspects and roles of these receptors in immunologic and oncogenic processes are discussed. SIGNIFICANCE STATEMENT: CXCR4 and atypical chemokine receptor 3 are two oncogenic G protein-coupled receptors that are highly upregulated in various tumors. Insight into the signalling properties of these receptors and the availability of modulators targeting these receptors are essential to assess their role in cancer.

AB - Chemokine receptors CXCR4 and atypical chemokine receptor 3 (ACKR3/CXCR7) are highly expressed in a range of tumors. Yet, their role in cancer progression is not well understood. This minireview series encompasses seven comprehensive reviews focusing on modulators (small molecules, pepducins, antibodies), structural aspects, spatio-temporal signaling properties, and phosphorylation/interactome of CXCR4 and ACKR3. Moreover, different (patho)physiologic aspects and roles of these receptors in immunologic and oncogenic processes are discussed. SIGNIFICANCE STATEMENT: CXCR4 and atypical chemokine receptor 3 are two oncogenic G protein-coupled receptors that are highly upregulated in various tumors. Insight into the signalling properties of these receptors and the availability of modulators targeting these receptors are essential to assess their role in cancer.

UR - http://www.scopus.com/inward/record.url?scp=85075094296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075094296&partnerID=8YFLogxK

U2 - 10.1124/mol.119.118364

DO - 10.1124/mol.119.118364

M3 - Article

VL - 96

SP - 735

EP - 736

JO - Molecular pharmacology

JF - Molecular pharmacology

SN - 0026-895X

IS - 6

ER -